01 — What is it?
Epitalon is a tetrapeptide studied in cell, animal and some human research, particularly around pineal/circadian biology, telomerase-related findings and aging models.
Database / Research Profiles / Epitalon / Epithalon
RESEARCH PROFILE
EPITALON / EPITHALON
Ala-Glu-Asp-Gly • pineal tetrapeptide
Aging / circadian biologyPreclinical + limited human observational research
EVIDENCE SNAPSHOTPRECLINICAL + LIMITED HUMAN OBSERVATIONAL RESEARCH
The literature includes human cell and observational work, but robust randomized clinical evidence for longevity outcomes is lacking.
Research-first: This profile summarizes published evidence and regulatory context. It is educational reference material, not a diagnosis, treatment recommendation, or personalized dosing protocol.
02 — Research category
Aging / circadian biology. Evidence strength is based on the availability and quality of human clinical data, not on popularity in the research-peptide market.
03 — Evidence map
Human evidence: LIMITED / NONEPreclinical evidence: YESPersonal dosing protocol: NOT PROVIDED
The literature includes human cell and observational work, but robust randomized clinical evidence for longevity outcomes is lacking.
04 — Mechanism / biology
Epitalon is a tetrapeptide studied in cell, animal and some human research, particularly around pineal/circadian biology, telomerase-related findings and aging models.
05 — Safety & limitations
Safety depends on the exact molecule, formulation, route, dose, indication and study population. Research-market products may differ in identity, purity, sterility or stability from materials used in published trials. Absence of reported adverse events in a small study does not establish long-term safety.
06 — Regulatory context
Regulatory status varies by compound and jurisdiction. Where an approved product exists, its approval applies only to specified formulations and indications. Investigational or research-market status should not be presented as equivalent to approval.